Graungaard, Tina
Novo Nordisk (Denmark)
3 papers on CoChat
Most cited papers
- Verified
Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: Results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (ONSET 1)
Russell-Jones, D., Bode, B. W., De Block, C., Franek, E., Heller, S. R., Mathieu, C., Philis-Tsimikas, A., Rose, L., Woo, V. C., Østerskov, A. B., et al. (2017) · Diabetes Care
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 177
- Verified
Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis
Albertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013) · Stroke
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 101
- Verified
Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
Mathieu, C., Bode, B. W., Franek, E., Philis‐Tsimikas, A., Rose, L., Graungaard, T., Birk Østerskov, A., & Russell‐Jones, D. (2018) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 95
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free